Please send your Inquiry here
Details Introduction
TOXICITY DATA with REFERENCE：
| 1. |
mmo-sat 18 µmol/L |
TCMUD8 Teratogenesis, Carcinogenesis, and Mutagenesis. 3 (1983),51. | ||
| 2. |
orl-rat LD50:7600 mg/kg |
ARZNAD Arzneimittel-Forschung. Drug Research. 28 (1978),2251. | ||
| 3. |
ipr-rat LD50:860 mg/kg |
ARZNAD Arzneimittel-Forschung. Drug Research. 28 (1978),2251. | ||
| 4. |
orl-mus LD50:5100 mg/kg |
ARZNAD Arzneimittel-Forschung. Drug Research. 28 (1978),2251. | ||
| 5. |
ipr-mus LD50:590 mg/kg |
ARZNAD Arzneimittel-Forschung. Drug Research. 28 (1978),2251. |
Consensus Reports：
SAFETY PROFILE：
Moderately toxic by intraperitoneal route. Mildly toxic by ingestion. Experimental reproductive effects. Mutation data reported. When heated to decomposition it emits toxic fumes of NOx.
Standards and Recommendations：
Analytical Methods：
Related Searches
Other Product
- 4-Cyclopentylcarbamoylmethoxyacetophenone
- Butanamide,N-(4-methylphenyl)-3-oxo-
- 2H-1-Benzopyran-5-ol,3,4-dihydro-2,7- dimethyl-6-(3-methyl-2-butenyl)-2-[(1E)- 4-methyl-1,3-pentadienyl]-
- 2-(diprop-2-enylamino)-1H-quinazolin-4-one
- Carbamic acid,[2-(pentyloxy)phenyl]-, 1-butyl-4-piperidinyl ester, monohydrochloride (9CI)
- 4H-1,3-Thiazine,5,6-dihydro-2-[(1E)-2-(3-methyl-2-thienyl)ethenyl]-
- Dibenzo[a,c]cycloocten-5(6H)-one,7,8-dihydro-3-hydroxy-1,2,10,11,12-pentamethoxy-6,7-dimethyl-, (6R,7R,12aR)-(9CI)
- Vincaleukoblastine,O4-deacetyl-, 4-ester with N,N-dimethylglycine
- 3-butylpurin-6-amine
- Cyclopropanecarboxylicacid, 2,2-dimethyl-3-(2-methyl-1-propen-1-yl)-, (2,4-dimethylphenyl)methylester, (1R,3R)-
- phenethyl 2-methyl-6-oxo-4-(2-propan-2-yloxyphenyl)-4,5-dihydro-1H-pyridine-3-carboxylate
- 2(1H)-Pyridinone,3,4-dihydro-3,4-dihydroxy-1-methyl-,(3S,4S)-(9CI)
- [4-[3-(tert-butylcarbamoyl)phenyl]phenyl] acetate
- 3-(2-AMINOETHYL)INDOL-5-OL CREATININE SULFATE
- Kloroperka N-O
- [4-[2-(1-piperidyl)ethyl]phenyl] 4-nitrobenzoate